FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mylan Pharmaceuticals Carvedilol Tablets Recall

Carvedilol Tablets, USP, 12

Mylan Pharmaceuticals Inc. · Morgantown, WV

Risk level
Class II
Reported by FDA
Feb 6, 2013
Recall ID
D-137-2013
Check your lot numberHow we source this data

Summary

Mylan Pharmaceuticals recalled Carvedilol Tablets starting Jan 16, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-137-2013 on Feb 6, 2013. Reason: Failed Tablet/Capsule Specifications: Product exceeds specification for tablet weight and tablet thickness. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specifications: Product exceeds specification for tablet weight and tablet thickness.

Product description

Carvedilol Tablets, USP, 12.5 mg, 500-count tablets per bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-3633-05, UPC 3 0378-3633-05 3.

Lot numbers, UPCs & expiration codes

Lot #: ZCMH12031, ZCMH12032, ZCMH12033, ZCMH12034, Exp 02/14

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-137-2013
Classification
Class II
Status
Terminated
Recall initiated
Jan 16, 2013
FDA report date
Feb 6, 2013
Quantity
11,580 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-137-2013, exactly as published.

Show all FDA fields
City
Morgantown
State
WV
Status
Terminated
Country
United States
Event ID
64154
Address
781 Chestnut Ridge Rd
Code information
Lot #: ZCMH12031, ZCMH12032, ZCMH12033, ZCMH12034, Exp 02/14
Postal code
26505-2730
Report date
Feb 6, 2013
Product type
Drugs
Recall number
D-137-2013
Classification
Class II
Recalling firm
Mylan Pharmaceuticals Inc.
Product quantity
11,580 bottles
Termination date
Dec 5, 2013
Reason for recall
Failed Tablet/Capsule Specifications: Product exceeds specification for tablet weight and tablet thickness.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carvedilol Tablets, USP, 12.5 mg, 500-count tablets per bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-3633-05, UPC 3 0378-3633-05 3.
Distribution pattern
Nationwide.
Recall initiation date
Jan 16, 2013
Initial firm notification
Letter
Center classification date
Jan 28, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-137-2013, published Feb 6, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls